John Gregory Beattie serves as Executive at BIOANALYTICAL SYSTEMS INC, where they oversee executive responsibilities. Since joining the company, John Gregory Beattie has executed 14 insider transactions totaling $904.7K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 10, 2024 involved receiving (via award) 20,000 shares valued at $0.
John Gregory Beattie currently holds 131,761 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Gregory Beattie has been a net buyer of BASI stock. They have purchased $904.7K and sold $0 worth of shares.
John Gregory Beattie's most recent insider trade was on Aug 10, 2024, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.12 |
| Discretionary |
| Feb 22, 2023 | NOTV | $35.0K | Purchase | 5,000 | $6.99 | Discretionary |
| Jan 18, 2023 | NOTV | $0 | Award | 7,101 | $N/A | Discretionary |
| Sep 9, 2022 | NOTV | $198.8K | Purchase | 8,900 | $22.34 | Discretionary |
| Feb 18, 2022 | NOTV | $23.9K | Purchase | 1,000 | $23.88 | Discretionary |
| Feb 17, 2022 | NOTV | $97.5K | Purchase | 4,600 | $21.19 | Discretionary |
| Feb 16, 2022 | NOTV | $137.5K | Purchase | 5,800 | $23.71 | Discretionary |
| Oct 22, 2021 | NOTV | $0 | Award | 954 | $N/A | Discretionary |
| May 13, 2021 | NOTV | $114.5K | Purchase | 5,000 | $22.91 | Discretionary |
| May 7, 2021 | NOTV | $0 | Award | 440 | $N/A | Discretionary |
| Mar 1, 2021 | BASI | $31.8K | Purchase | 1,712 | $18.60 | Discretionary |
| Feb 23, 2021 | BASI | $116.0K | Purchase | 8,288 | $14.00 | Discretionary |
| Feb 15, 2021 | BASI | $0 | Award | 15,000 | $N/A | Discretionary |